Spruce Street Capital »

Century Therapeutics shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.9M 4.1M 2.45

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Century Therapeutics

RA Capital Management
TCG Crossover Management
Versant Venture Management
Deep Track Capital
Commodore Capital
VR Adviser
Rtw Investments
Point72 Asset Management
Vanguard Capital Management
Balyasny Asset Management
Millennium Management
Spruce Street Capital
Adage Capital Partners GP
Woodline Partners
Seven Fleet Capital Management

View all funds holding Century Therapeutics